Published in Circ Res on September 18, 2008
Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res (2009) 2.10
Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion. Circ Res (2011) 2.10
Separation and detection of large phosphoproteins using Phos-tag SDS-PAGE. Nat Protoc (2009) 1.97
Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res (2012) 1.95
Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res (2009) 1.66
Mitochondrial dysfunction in cancer. Front Oncol (2013) 1.57
Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics (2010) 1.41
Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther (2010) 1.41
Free tubulin modulates mitochondrial membrane potential in cancer cells. Cancer Res (2010) 1.23
Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol (2011) 1.17
Redox modification of cell signaling in the cardiovascular system. J Mol Cell Cardiol (2011) 1.15
GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice. J Clin Invest (2010) 1.15
Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol (2011) 1.14
Affixing N-terminal α-helix to the wall of the voltage-dependent anion channel does not prevent its voltage gating. J Biol Chem (2012) 1.13
Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injury. Front Physiol (2014) 1.10
Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons. PLoS One (2009) 1.09
Nuclear and mitochondrial signalling Akts in cardiomyocytes. Cardiovasc Res (2009) 1.09
VDAC inhibition by tubulin and its physiological implications. Biochim Biophys Acta (2011) 1.08
Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem (2013) 1.07
Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol Sci (2013) 1.07
Phosphorylation of voltage-dependent anion channel by serine/threonine kinases governs its interaction with tubulin. PLoS One (2011) 1.07
Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. Mol Interv (2010) 1.00
The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes. Am J Physiol Heart Circ Physiol (2015) 0.99
Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling. Circ Res (2014) 0.98
The GSK-3 family as therapeutic target for myocardial diseases. Circ Res (2015) 0.97
Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function. Cardiovasc Res (2009) 0.96
Warburg revisited: regulation of mitochondrial metabolism by voltage-dependent anion channels in cancer cells. J Pharmacol Exp Ther (2012) 0.94
What makes the mitochondria a killer? Can we condition them to be less destructive? Biochim Biophys Acta (2010) 0.94
Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2). J Biol Chem (2014) 0.92
AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. World J Gastroenterol (2010) 0.92
ATP/ADP ratio, the missed connection between mitochondria and the Warburg effect. Mitochondrion (2014) 0.92
What can we learn about cardioprotection from the cardiac mitochondrial proteome? Cardiovasc Res (2010) 0.90
VDAC proteomics: post-translation modifications. Biochim Biophys Acta (2011) 0.90
Chronic ethanol consumption enhances sensitivity to Ca(2+)-mediated opening of the mitochondrial permeability transition pore and increases cyclophilin D in liver. Am J Physiol Gastrointest Liver Physiol (2010) 0.90
Mitochondrial therapeutics for cardioprotection. Curr Pharm Des (2011) 0.89
Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure. Congest Heart Fail (2011) 0.87
Intracellular zinc release-activated ERK-dependent GSK-3β-p53 and Noxa-Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury. Cell Death Differ (2011) 0.87
Role of the MPTP in conditioning the heart - translatability and mechanism. Br J Pharmacol (2015) 0.86
Cardioprotection and altered mitochondrial adenine nucleotide transport. Basic Res Cardiol (2009) 0.86
Facilitation of mitochondrial outer and inner membrane permeabilization and cell death in oxidative stress by a novel Bcl-2 homology 3 domain protein. J Biol Chem (2009) 0.85
The L-type Ca(2+) channel facilitates abnormal metabolic activity in the cTnI-G203S mouse model of hypertrophic cardiomyopathy. J Physiol (2016) 0.84
miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One (2014) 0.84
Regulation of mitochondrial function by voltage dependent anion channels in ethanol metabolism and the Warburg effect. Biochim Biophys Acta (2011) 0.83
Flurbiprofen, a cyclooxygenase inhibitor, protects mice from hepatic ischemia/reperfusion injury by inhibiting GSK-3β signaling and mitochondrial permeability transition. Mol Med (2012) 0.83
Overcoming an energy crisis?: an adaptive role of glycogen synthase kinase-3 inhibition in ischemia/reperfusion. Circ Res (2008) 0.83
ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity. Am J Physiol Heart Circ Physiol (2015) 0.83
Ischemia/Reperfusion injury protection by mesenchymal stem cell derived antioxidant capacity. Stem Cells Dev (2013) 0.82
Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies. Aging Dis (2016) 0.81
Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome. Mol Cell Proteomics (2015) 0.79
Perspectives on: SGP symposium on mitochondrial physiology and medicine: mitochondrial proteome design: from molecular identity to pathophysiological regulation. J Gen Physiol (2012) 0.78
Does the voltage dependent anion channel modulate cardiac ischemia-reperfusion injury? Biochim Biophys Acta (2011) 0.77
Mitigation of carbon tetrachloride-induced hepatic injury by methylene blue, a repurposed drug, is mediated by dual inhibition of GSK3β downstream of PKA. Br J Pharmacol (2014) 0.77
MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression. J Biol Chem (2016) 0.77
Mitochondrial adenine nucleotide transport and cardioprotection. J Mol Cell Cardiol (2011) 0.77
Divergent Effects of miR-181 Family Members on Myocardial Function Through Protective Cytosolic and Detrimental Mitochondrial microRNA Targets. J Am Heart Assoc (2017) 0.76
Characterization of the sex-dependent myocardial S-nitrosothiol proteome. Am J Physiol Heart Circ Physiol (2015) 0.76
The role of tubulin in the mitochondrial metabolism and arrangement in muscle cells. J Bioenerg Biomembr (2014) 0.76
Gsk-3β inhibitors mimic the cardioprotection mediated by ischemic pre- and postconditioning in hypertensive rats. Biomed Res Int (2013) 0.75
GSK3β and VDAC Involvement in ER Stress and Apoptosis Modulation during Orthotopic Liver Transplantation. Int J Mol Sci (2017) 0.75
Circadian influences on myocardial infarction. Front Physiol (2014) 0.75
VDAC2-specific cellular functions and the underlying structure. Biochim Biophys Acta (2016) 0.75
VDAC-Tubulin, an Anti-Warburg Pro-Oxidant Switch. Front Oncol (2017) 0.75
Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target. Front Physiol (2017) 0.75
Decrypting Strong and Weak Single-Walled Carbon Nanotubes Interactions with Mitochondrial Voltage-Dependent Anion Channels Using Molecular Docking and Perturbation Theory. Sci Rep (2017) 0.75
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature (1999) 8.70
Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol (2007) 5.60
High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett (1997) 5.21
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest (2004) 4.97
Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res (2004) 3.96
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell (2004) 3.62
Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem (2001) 3.33
VDAC: the channel at the interface between mitochondria and the cytosol. Mol Cell Biochem (2004) 3.26
Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J Biol Chem (1987) 3.19
Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J (1995) 2.92
Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem (2000) 2.89
Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. J Biol Chem (2001) 2.76
Voltage-dependent anion channel (VDAC) as mitochondrial governator--thinking outside the box. Biochim Biophys Acta (2005) 2.57
Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective. Circ Res (2002) 2.50
Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci U S A (2000) 2.46
Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res (2004) 2.40
Signaling pathways in ischemic preconditioning. Heart Fail Rev (2007) 2.26
Inhibition of glycogen synthase kinase 3beta during heart failure is protective. Circ Res (2007) 2.22
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev (2007) 2.14
A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J Biol Chem (1994) 1.94
Glycogen synthase kinase-3--an overview of an over-achieving protein kinase. Curr Drug Targets (2006) 1.88
Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res (2004) 1.69
Altered mitochondrial sensitivity for ADP and maintenance of creatine-stimulated respiration in oxidative striated muscles from VDAC1-deficient mice. J Biol Chem (2000) 1.51
Cloning and functional expression in yeast of two human isoforms of the outer mitochondrial membrane channel, the voltage-dependent anion channel. J Biol Chem (1993) 1.46
Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res (2006) 1.37
G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res (2004) 1.27
The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown. Ann N Y Acad Sci (2008) 1.25
GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol (2007) 1.24
Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol (2006) 1.19
Potassium channel openers are uncoupling protonophores: implication in cardioprotection. FEBS Lett (2004) 1.18
A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC. Proc Natl Acad Sci U S A (2006) 1.13
Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition. Expert Opin Ther Targets (2005) 1.11
Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Cardiovasc Res (2006) 1.04
Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J Mol Cell Cardiol (1991) 1.01
A novel mouse mitochondrial voltage-dependent anion channel gene localizes to chromosome 8. Genomics (1996) 0.94
Past and present course of cardioprotection against ischemia-reperfusion injury. J Appl Physiol (1985) (2007) 0.92
Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion. Am J Physiol Heart Circ Physiol (2008) 0.91
Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev (2008) 5.52
Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation (2009) 3.45
The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat Cell Biol (2013) 3.39
Three techniques for integrating data in mixed methods studies. BMJ (2010) 3.19
Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ Res (2004) 2.98
Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res (2007) 2.97
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91
Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res (2007) 2.91
Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res (2006) 2.84
Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective. Circ Res (2002) 2.50
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res (2006) 2.33
Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload. Circ Res (2007) 2.31
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J (2009) 2.29
Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol (2011) 2.15
Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Invest (2010) 2.12
The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab (2007) 2.11
Vitamin D deficiency in multicultural primary care: a case series of 299 patients. Br J Gen Pract (2007) 2.02
Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res (2012) 1.95
Preconditioning: the mitochondrial connection. Annu Rev Physiol (2007) 1.93
Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study. BMC Health Serv Res (2007) 1.91
Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood (2011) 1.91
Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation (2003) 1.80
The quality of mixed methods studies in health services research. J Health Serv Res Policy (2008) 1.75
Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation (2005) 1.72
Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res (2004) 1.69
Qualitative study investigating the process of giving anti-smoking advice in general practice. Patient Educ Couns (2004) 1.67
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Protein S-nitrosylation and cardioprotection. Circ Res (2010) 1.63
Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling? Free Radic Biol Med (2012) 1.61
A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm (2007) 1.61
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol (2009) 1.59
Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res (2007) 1.57
Ethnic differences in self-harm, rates, characteristics and service provision: three-city cohort study. Br J Psychiatry (2010) 1.57
Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation (2009) 1.56
Cyclophilin D modulates mitochondrial acetylome. Circ Res (2013) 1.53
Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture. Circ Res (2010) 1.48
Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol (2005) 1.47
Retracted The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature (2012) 1.44
S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal (2006) 1.43
Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol (2004) 1.41
Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A (2009) 1.41
Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol (2008) 1.41
The 5-tier system of assessing fetal heart rate tracings is superior to the 3-tier system in identifying fetal acidemia. Am J Obstet Gynecol (2011) 1.40
Advancing geriatrics education: an efficient faculty development program for academic hospitalists increases geriatric teaching. J Hosp Med (2010) 1.40
Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res (2010) 1.40
Characterization of potential S-nitrosylation sites in the myocardium. Am J Physiol Heart Circ Physiol (2011) 1.37
Nurse and pharmacist supplementary prescribing in the UK--a thematic review of the literature. Health Policy (2007) 1.33
Cardiac-specific ablation of the Na+-Ca2+ exchanger confers protection against ischemia/reperfusion injury. Circ Res (2005) 1.32
G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res (2004) 1.27
Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J (2005) 1.27
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest (2011) 1.26
Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos (2007) 1.25
2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol (2011) 1.24
Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci U S A (2011) 1.24
Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation. J Physiol (2010) 1.22
Multidisciplinary, interdisciplinary, or dysfunctional? Team working in mixed-methods research. Qual Health Res (2008) 1.19
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol (2007) 1.19
Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem (2011) 1.18
Skeletal muscle ATP kinetics are impaired in frail mice. Age (Dordr) (2013) 1.18
S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol (2011) 1.16
Stakeholders' views of UK nurse and pharmacist supplementary prescribing. J Health Serv Res Policy (2008) 1.14
The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J (2005) 1.13
Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO. Am J Physiol Heart Circ Physiol (2002) 1.13
Structural issues affecting mixed methods studies in health research: a qualitative study. BMC Med Res Methodol (2009) 1.12
Learning to prescribe - pharmacists' experiences of supplementary prescribing training in England. BMC Med Educ (2008) 1.12
Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition. Expert Opin Ther Targets (2005) 1.11
Medical device development: the challenge for ergonomics. Appl Ergon (2007) 1.10
Psychosocial assessment following self-harm: results from the multi-centre monitoring of self-harm project. J Affect Disord (2007) 1.10
Use of an interactive, telephone-based self-management support program to identify adverse events among ambulatory diabetes patients. J Gen Intern Med (2008) 1.10
The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol (2011) 1.10
Targeting mitochondrial ATP-sensitive potassium channels--a novel approach to neuroprotection. Brain Res Brain Res Rev (2004) 1.09
Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication. Circ Res (2012) 1.09